Advertisement
CARE vs HBNC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARE is a Buy and HBNC is a Hold.
Momentum Indicator for CARE turns positive, indicating new upward trend
CARE saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In 53 of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CARE just turned positive on October 02, 2026. Looking at past instances where CARE's MACD turned positive, the stock continued to rise in 26 of 37 cases over the following month. The odds of a continued upward trend are 70%.
Following a +1.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARE advanced for three days, in 211 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
CARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for CARE entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CARE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.313) is normal, around the industry mean (1.271). P/E Ratio (5.271) is within average values for comparable stocks, (13.247). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (1.190). Dividend Yield (0.013) settles around the average of (0.035) among similar stocks. P/S Ratio (3.140) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
HBNC in upward trend: 10-day moving average moved above 50-day moving average on October 23, 2026
The 10-day moving average for HBNC crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HBNC as a result. In 53 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for HBNC just turned positive on October 02, 2026. Looking at past instances where HBNC's MACD turned positive, the stock continued to rise in 27 of 44 cases over the following month. The odds of a continued upward trend are 61%.
HBNC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where HBNC advanced for three days, in 190 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HBNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
HBNC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HBNC entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.440) is normal, around the industry mean (1.269). P/E Ratio (-6.248) is within average values for comparable stocks, (13.317). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (1.190). Dividend Yield (0.031) settles around the average of (0.035) among similar stocks. P/S Ratio (3.319) is also within normal values, averaging (3.738).
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. HBNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HBNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
CARE | HBNC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 20 | 69 | |
SMR RATING 1..100 | 23 | 67 | |
PRICE GROWTH RATING 1..100 | 41 | 43 | |
P/E GROWTH RATING 1..100 | 93 | 98 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HBNC's Valuation (1) in the Regional Banks industry is somewhat better than the same rating for CARE (47). This means that HBNC’s stock grew somewhat faster than CARE’s over the last 12 months.
CARE's Profit vs Risk Rating (20) in the Regional Banks industry is somewhat better than the same rating for HBNC (69). This means that CARE’s stock grew somewhat faster than HBNC’s over the last 12 months.
CARE's SMR Rating (23) in the Regional Banks industry is somewhat better than the same rating for HBNC (67). This means that CARE’s stock grew somewhat faster than HBNC’s over the last 12 months.
CARE's Price Growth Rating (41) in the Regional Banks industry is in the same range as HBNC (43). This means that CARE’s stock grew similarly to HBNC’s over the last 12 months.
CARE's P/E Growth Rating (93) in the Regional Banks industry is in the same range as HBNC (98). This means that CARE’s stock grew similarly to HBNC’s over the last 12 months.
| CARE | HBNC | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 42% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 64% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 61% |
| Advances ODDS (%) | 3 days ago 65% | 2 days ago 63% |
| Declines ODDS (%) | 6 days ago 61% | 11 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 61% | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 54% | 2 days ago 63% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CARE’s FA Score shows that 2 FA rating(s) are green while HBNC’s FA Score has 1 green FA rating(s).
- CARE’s FA Score: 2 green, 3 red.
- HBNC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CARE’s TA Score shows that 4 TA indicator(s) are bullish while HBNC’s TA Score has 5 bullish TA indicator(s).
- CARE’s TA Score: 4 bullish, 3 bearish.
- HBNC’s TA Score: 5 bullish, 5 bearish.
Price Growth
CARE (@Regional Banks) experienced а +1.19% price change this week, while HBNC (@Regional Banks) price change was +4.68% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was +2.29%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was +9.12%.
Reported Earning Dates
CARE is expected to report earnings on Jan 28, 2027.
HBNC is expected to report earnings on Jan 27, 2027.
Industries' Descriptions
@Regional Banks (+2.29% weekly)Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
Advertisement
HBNC and
Correlation & Price change
A.I.dvisor indicates that over the last year, HBNC has been closely correlated with BY. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if HBNC jumps, then BY could also see price increases.
| Ticker / NAME | Correlation To HBNC | 1D Price Change % | ||
|---|---|---|---|---|
| HBNC | 100% | +1.90% | ||
| BY - HBNC | 86% Closely correlated | +1.08% | ||
| UVSP - HBNC | 85% Closely correlated | -0.33% | ||
| BUSE - HBNC | 84% Closely correlated | -0.13% | ||
| EFSC - HBNC | 83% Closely correlated | +0.56% | ||
| FMBH - HBNC | 83% Closely correlated | +0.24% | ||
More | ||||